Immunoblastic Lymphadenopathy
"Immunoblastic Lymphadenopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
| Descriptor ID |
D007119
|
| MeSH Number(s) |
C15.604.338.500 C15.604.515.509 C20.683.515.501
|
| Concept/Terms |
Immunoblastic Lymphadenopathy- Immunoblastic Lymphadenopathy
- Angioimmunoblastic Lymphadenopathy
- Angioimmunoblastic Lymphadenopathies
- Lymphadenopathies, Angioimmunoblastic
- Lymphadenopathy, Angioimmunoblastic
- Lymphadenopathy, Immunoblastic
- Immunoblastic Lymphadenopathies
- Lymphadenopathies, Immunoblastic
|
Below are MeSH descriptors whose meaning is more general than "Immunoblastic Lymphadenopathy".
Below are MeSH descriptors whose meaning is more specific than "Immunoblastic Lymphadenopathy".
This graph shows the total number of publications written about "Immunoblastic Lymphadenopathy" by people in this website by year, and whether "Immunoblastic Lymphadenopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoblastic Lymphadenopathy" by people in Profiles.
-
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 03; 20(3):285-308.
-
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant. Br J Haematol. 2022 04; 197(2):212-222.
-
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-?B-Dependent Mechanism. Cancer Cell. 2019 09 16; 36(3):268-287.e10.
-
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017 03; 176(5):750-758.
-
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer. 2014 Jul 01; 120(13):1993-9.
-
Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis. Am J Hematol. 2011 Aug; 86(8):690-3.
-
Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol. 2010 Jan; 41(1):79-87.
-
The role of the perifollicular sinus in determining the complex immunoarchitecture of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2004 Dec; 28(12):1632-40.
-
Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med. 1995 Apr; 119(4):377-80.
-
B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood. 1993 Jul 01; 82(1):241-6.